Abstract: A sample pretreatment kit for detecting virus infectivity includes a photoactivatable dye capable of intercalating into a nucleic acid, and a nuclease capable of degrading the nucleic acid. The photoactivatable dye includes PMA dye, PMAxx dye, EMA, platinum compounds, or palladium compounds. The method for detecting virus infectivity includes steps of: (a) dividing a clinical sample into a test sample and a control sample; (b) treating the test sample with a photoactivatable dye and a nuclease; (c) exposing the test sample to a light for photoactivation; (d) amplifying a target nucleic acid in the test sample and the control sample; and (e) determining virus infectivity based on amplification results of the test sample and the control sample.

Abstract: A transport medium for a microorganism is provided. The transport medium includes at least one chaotropic substance, at least one acid, at least one buffer, at least one chelating agent, and at least one detergent. The transport medium is able to inactivate bacteria and viruses at the time of sample collection, stabilize and preserve microbial nucleic acids at ambient temperature for extended periods of time.

Abstract: A method for detecting infectivity of a human coronavirus is provided. The method includes steps of: (a) dividing a testing sample into a first sample and a second sample; (b) treating the first sample with an intercalating dye or chemical; (c) exposing the first sample to a light for photo-activation; (d) amplifying targeted nucleic acids in the first sample and the second sample; and (e) determining infectivity of the human coronavirus based on amplification results of the first sample and the second sample.

Abstract: A kit for simultaneously detecting HSV1 and HSV2 includes a forward primer and a reverse primer specific to HSV1, and a forward primer and a reverse primer specific to HSV2. The forward primer specific to HSV1 has a sequence of SEQ ID NO: 1 or SEQ ID NO: 4, and the reverse primer specific to HSV1 has a sequence of SEQ ID NO: 2 or SEQ ID NO: 7. The forward primer specific to HSV2 has a sequence of SEQ ID NO: 6, and the reverse primer specific to HSV2 has a sequence of SEQ ID NO: 7.

Abstract: An additive composition used in a loop mediated isothermal amplification (LAMP) reaction for reducing a threshold time for a positive sample includes but not limited to EDTA, EGTA, BSA, DMSO, nonionic surfactants, and polymers, and the additive composition used in LAMP reactions includes at least one of the above mentioned additives and may be any combination use of the additives.

Abstract: A nucleic acid analysis apparatus with isothermal based amplification includes a chamber, a fluid delivery unit, a thermal unit, a rotational driven unit and at least one optical unit. The chamber includes a cartridge mounted therein. The fluid delivery unit is connected with the chamber and adapted to transport reagents within the cartridge for sample purification and/or nucleic acid extraction. The thermal unit is disposed in the chamber and adapted to provide a predefined temperature for nucleic acid amplification. The rotational driven unit is connected with the chamber and capable of rotating the cartridge with a predefined program. The at least one optical unit is disposed on the chamber and includes plural optical components for detection.

Abstract: A kit for simultaneously detecting HSV1 and HSV2 includes a forward primer and a reverse primer specific to HSV1, and a forward primer and a reverse primer specific to HSV2. The forward primer specific to HSV1 has a sequence of SEQ ID NO: 1 or SEQ ID NO: 4, and the reverse primer specific to HSV1 has a sequence of SEQ ID NO: 2 or SEQ ID NO: 7. The forward primer specific to HSV2 has a sequence of SEQ ID NO: 6, and the reverse primer specific to HSV2 has a sequence of SEQ ID NO: 7.

Abstract: An additive composition used in a loop mediated isothermal amplification (LAMP) reaction for reducing a threshold time for a positive sample includes but not limited to EDTA, EGTA, BSA, DMSO, nonionic surfactants, and polymers, and the additive composition used in LAMP reactions includes at least one of the above mentioned additives and may be any combination use of the additives.

Abstract: A nucleic acid analysis apparatus with isothermal based amplification includes a chamber, a fluid delivery unit, a thermal unit, a rotational driven unit and at least one optical unit. The chamber includes a cartridge mounted therein. The fluid delivery unit is connected with the chamber and adapted to transport reagents within the cartridge for sample purification and/or nucleic acid extraction. The thermal unit is disposed in the chamber and adapted to provide a predefined temperature for nucleic acid amplification. The rotational driven unit is connected with the chamber and capable of rotating the cartridge with a predefined program. The at least one optical unit is disposed on the chamber and includes plural optical components for detection.